MAP2K7 and cancer: Accordingly, EGF-induced ERK activation has previously been found to be enhanced and/or sustained in T-REx293T cells expressing NS-associated RIT1 mutants [21], and ectopic expression of NS- and cancer-related RIT1 mutants in PC6 cells induced phosphorylation of both MEK and ERK [25, 37].